Serum Metabolomic Signatures Indicate Oxidative Membrane Lipid Remodeling in β-Thalassemia.

Alexandros Makis, Eleftheria Hatzimichael, Theodoros Palianopoulos, Dimitra Papagiannaki, Eleni Kapsali, Evangelos Gikas, Vasilios Sakkas

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

A fatty acid metabolism-based deep learning model predicts biochemical recurrence and identifies NUDT19 as a candidate metabolic factor in prostate cancer.World journal of surgical oncology · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexandros MakisDepartment of Pediatrics, University Hospital of Ioannina, Faculty of Medicine, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0003-0142-6110

Eleftheria HatzimichaelDepartment of Hematology, University Hospital of Ioannina, Faculty of Medicine, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0002-4408-5646

Theodoros PalianopoulosDepartment of Pediatrics, University Hospital of Ioannina, Faculty of Medicine, University of Ioannina, 45500 Ioannina, Greece.

Dimitra PapagiannakiLaboratory of Analytical Chemistry, Department of Chemistry, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0002-9354-5557

Eleni KapsaliDepartment of Hematology, University Hospital of Ioannina, Faculty of Medicine, University of Ioannina, 45500 Ioannina, Greece.

Evangelos GikasLaboratory of Pharmaceutical Analysis, School of Pharmacy, University of Athens, 15744 Athens, Greece.ORCID 0000-0002-0107-9991

Vasilios SakkasLaboratory of Analytical Chemistry, Department of Chemistry, University of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0003-0536-5933

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

arachidonic acidbile acidsiron overloadlysophosphatidylcholinephospholipase A2serum metabolomicsβ-thalassemia

Identifiers

PMID41893322

DOI10.3390/metabo16030170

PMCPMC13027618

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.